Chemicals - Specialty
Compare Stocks
3 / 10Stock Comparison
ECVT vs ASIX vs IOSP
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals
Chemicals - Specialty
ECVT vs ASIX vs IOSP — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Chemicals - Specialty | Chemicals | Chemicals - Specialty |
| Market Cap | $1.53B | $796M | $1.91B |
| Revenue (TTM) | $819M | $1.52B | $1.78B |
| Net Income (TTM) | $-63M | $49M | $117M |
| Gross Margin | 22.6% | 10.8% | 27.7% |
| Operating Margin | 15.4% | 4.2% | 8.7% |
| Forward P/E | 22.9x | 15.7x | 15.5x |
| Total Debt | $431M | $381M | $90M |
| Cash & Equiv. | $197M | $20M | $293M |
ECVT vs ASIX vs IOSP — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Ecovyst Inc. (ECVT) | 100 | 111.3 | +11.3% |
| AdvanSix Inc. (ASIX) | 100 | 202.8 | +102.8% |
| Innospec Inc. (IOSP) | 100 | 99.4 | -0.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ECVT vs ASIX vs IOSP
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ECVT is the clearest fit if your priority is growth exposure.
- Rev growth 2.7%, EPS growth -9.2%, 3Y rev CAGR -4.1%
- 2.7% revenue growth vs IOSP's -3.7%
- +102.7% vs IOSP's -14.9%
ASIX is the clearest fit if your priority is dividends.
- 2.6% yield, vs IOSP's 2.2%, (1 stock pays no dividend)
IOSP carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 12 yrs, beta 0.70, yield 2.2%
- 84.4% 10Y total return vs ASIX's 60.6%
- Lower volatility, beta 0.70, Low D/E 6.7%, current ratio 2.79x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 2.7% revenue growth vs IOSP's -3.7% | |
| Value | Lower P/E (15.5x vs 15.7x), PEG 0.48 vs 8.38 | |
| Quality / Margins | 6.6% margin vs ECVT's -7.7% | |
| Stability / Safety | Beta 0.70 vs ECVT's 0.90, lower leverage | |
| Dividends | 2.6% yield, vs IOSP's 2.2%, (1 stock pays no dividend) | |
| Momentum (1Y) | +102.7% vs IOSP's -14.9% | |
| Efficiency (ROA) | 6.5% ROA vs ECVT's -4.2%, ROIC 11.2% vs 4.2% |
ECVT vs ASIX vs IOSP — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ECVT vs ASIX vs IOSP — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ECVT leads in 2 of 6 categories
IOSP leads 1 • ASIX leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ECVT leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
IOSP is the larger business by revenue, generating $1.8B annually — 2.2x ECVT's $819M. IOSP is the more profitable business, keeping 6.6% of every revenue dollar as net income compared to ECVT's -7.7%. On growth, ECVT holds the edge at +32.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $819M | $1.5B | $1.8B |
| EBITDAEarnings before interest/tax | $136M | $143M | $198M |
| Net IncomeAfter-tax profit | -$63M | $49M | $117M |
| Free Cash FlowCash after capex | $84M | $6M | $88M |
| Gross MarginGross profit ÷ Revenue | +22.6% | +10.8% | +27.7% |
| Operating MarginEBIT ÷ Revenue | +15.4% | +4.2% | +8.7% |
| Net MarginNet income ÷ Revenue | -7.7% | +3.2% | +6.6% |
| FCF MarginFCF ÷ Revenue | +10.2% | +0.4% | +4.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +32.6% | +9.4% | -2.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.3% | -8.8% | +167.7% |
Valuation Metrics
Evenly matched — ASIX and IOSP each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 13.3x trailing earnings, ASIX trades at a 19% valuation discount to IOSP's 16.4x P/E. Adjusting for growth (PEG ratio), IOSP offers better value at 0.51x vs ASIX's 7.10x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $1.5B | $796M | $1.9B |
| Enterprise ValueMkt cap + debt − cash | $1.8B | $1.2B | $1.7B |
| Trailing P/EPrice ÷ TTM EPS | -22.90x | 13.34x | 16.41x |
| Forward P/EPrice ÷ next-FY EPS est. | 22.87x | 15.74x | 15.45x |
| PEG RatioP/E ÷ EPS growth rate | — | 7.10x | 0.51x |
| EV / EBITDAEnterprise value multiple | 13.28x | 7.86x | 8.29x |
| Price / SalesMarket cap ÷ Revenue | 2.11x | 0.52x | 1.07x |
| Price / BookPrice ÷ Book value/share | 2.68x | 0.80x | 1.44x |
| Price / FCFMarket cap ÷ FCF | 21.87x | 124.10x | 21.68x |
Profitability & Efficiency
IOSP leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
IOSP delivers a 9.0% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-10 for ECVT. IOSP carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to ECVT's 0.71x.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | -10.2% | +6.0% | +9.0% |
| ROA (TTM)Return on assets | -4.2% | +2.9% | +6.5% |
| ROICReturn on invested capital | +4.2% | +4.4% | +11.2% |
| ROCEReturn on capital employed | +4.6% | +5.3% | +11.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.71x | 0.47x | 0.07x |
| Net DebtTotal debt minus cash | $234M | $361M | -$203M |
| Cash & Equiv.Liquid assets | $197M | $20M | $293M |
| Total DebtShort + long-term debt | $431M | $381M | $90M |
| Interest CoverageEBIT ÷ Interest expense | 2.08x | 7.92x | — |
Total Returns (Dividends Reinvested)
ECVT leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ECVT five years ago would be worth $11,544 today (with dividends reinvested), compared to $8,168 for IOSP. Over the past 12 months, ECVT leads with a +102.7% total return vs IOSP's -14.9%. The 3-year compound annual growth rate (CAGR) favors ECVT at 9.9% vs ASIX's -9.4% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | +40.9% | +40.3% | +0.5% |
| 1-Year ReturnPast 12 months | +102.7% | +8.2% | -14.9% |
| 3-Year ReturnCumulative with dividends | +32.9% | -25.6% | -17.3% |
| 5-Year ReturnCumulative with dividends | +15.4% | -15.9% | -18.3% |
| 10-Year ReturnCumulative with dividends | +9.9% | +60.6% | +84.4% |
| CAGR (3Y)Annualised 3-year return | +9.9% | -9.4% | -6.1% |
Risk & Volatility
Evenly matched — ECVT and IOSP each lead in 1 of 2 comparable metrics.
Risk & Volatility
IOSP is the less volatile stock with a 0.70 beta — it tends to amplify market swings less than ECVT's 0.90 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ECVT currently trades 93.5% from its 52-week high vs IOSP's 80.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.90x | 0.81x | 0.70x |
| 52-Week HighHighest price in past year | $14.94 | $26.73 | $95.55 |
| 52-Week LowLowest price in past year | $6.69 | $14.10 | $65.58 |
| % of 52W HighCurrent price vs 52-week peak | +93.5% | +89.8% | +80.2% |
| RSI (14)Momentum oscillator 0–100 | 66.9 | 60.6 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 2.2M | 453K | 221K |
Analyst Outlook
Evenly matched — ASIX and IOSP each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ECVT as "Buy", ASIX as "Buy", IOSP as "Hold". Consensus price targets imply 50.1% upside for IOSP (target: $115) vs -30.8% for ECVT (target: $10). For income investors, ASIX offers the higher dividend yield at 2.62% vs IOSP's 2.21%.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $9.67 | $22.00 | $115.00 |
| # AnalystsCovering analysts | 6 | 6 | 9 |
| Dividend YieldAnnual dividend ÷ price | — | +2.6% | +2.2% |
| Dividend StreakConsecutive years of raises | 2 | 0 | 12 |
| Dividend / ShareAnnual DPS | — | $0.63 | $1.70 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.1% | +0.2% | 0.0% |
ECVT leads in 2 of 6 categories (Income & Cash Flow, Total Returns). IOSP leads in 1 (Profitability & Efficiency). 3 tied.
ECVT vs ASIX vs IOSP: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ECVT or ASIX or IOSP a better buy right now?
For growth investors, Ecovyst Inc.
(ECVT) is the stronger pick with 2. 7% revenue growth year-over-year, versus -3. 7% for Innospec Inc. (IOSP). AdvanSix Inc. (ASIX) offers the better valuation at 13. 3x trailing P/E (15. 7x forward), making it the more compelling value choice. Analysts rate Ecovyst Inc. (ECVT) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ECVT or ASIX or IOSP?
On trailing P/E, AdvanSix Inc.
(ASIX) is the cheapest at 13. 3x versus Innospec Inc. at 16. 4x. On forward P/E, Innospec Inc. is actually cheaper at 15. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Innospec Inc. wins at 0. 48x versus AdvanSix Inc. 's 8. 38x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — ECVT or ASIX or IOSP?
Over the past 5 years, Ecovyst Inc.
(ECVT) delivered a total return of +15. 4%, compared to -18. 3% for Innospec Inc. (IOSP). Over 10 years, the gap is even starker: IOSP returned +84. 4% versus ECVT's +9. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ECVT or ASIX or IOSP?
By beta (market sensitivity over 5 years), Innospec Inc.
(IOSP) is the lower-risk stock at 0. 70β versus Ecovyst Inc. 's 0. 90β — meaning ECVT is approximately 30% more volatile than IOSP relative to the S&P 500. On balance sheet safety, Innospec Inc. (IOSP) carries a lower debt/equity ratio of 7% versus 71% for Ecovyst Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ECVT or ASIX or IOSP?
By revenue growth (latest reported year), Ecovyst Inc.
(ECVT) is pulling ahead at 2. 7% versus -3. 7% for Innospec Inc. (IOSP). On earnings-per-share growth, the picture is similar: Innospec Inc. grew EPS 228. 9% year-over-year, compared to -916. 7% for Ecovyst Inc.. Over a 3-year CAGR, IOSP leads at -3. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ECVT or ASIX or IOSP?
Innospec Inc.
(IOSP) is the more profitable company, earning 6. 6% net margin versus -9. 8% for Ecovyst Inc. — meaning it keeps 6. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ECVT leads at 9. 0% versus 4. 4% for ASIX. At the gross margin level — before operating expenses — IOSP leads at 27. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ECVT or ASIX or IOSP more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Innospec Inc. (IOSP) is the more undervalued stock at a PEG of 0. 48x versus AdvanSix Inc. 's 8. 38x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Innospec Inc. (IOSP) trades at 15. 5x forward P/E versus 22. 9x for Ecovyst Inc. — 7. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IOSP: 50. 1% to $115. 00.
08Which pays a better dividend — ECVT or ASIX or IOSP?
In this comparison, ASIX (2.
6% yield), IOSP (2. 2% yield) pay a dividend. ECVT does not pay a meaningful dividend and should not be held primarily for income.
09Is ECVT or ASIX or IOSP better for a retirement portfolio?
For long-horizon retirement investors, Innospec Inc.
(IOSP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 70), 2. 2% yield). Both have compounded well over 10 years (IOSP: +84. 4%, ECVT: +9. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ECVT and ASIX and IOSP?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ECVT is a small-cap quality compounder stock; ASIX is a small-cap deep-value stock; IOSP is a small-cap deep-value stock. ASIX, IOSP pay a dividend while ECVT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.